About us

About health economics

Health economics is concerned with the efficient, effective, and equitable use of resources. Health economics makes it possible for decision-makers in the health sector to compare the costs and benefits of their actions and identify the how best to use the available resources to improve health outcomes.

What we do

We undertake a variety of methodological and applied health economics research to inform policy and resource allocation decisions in Australia and overseas. These include econometrics analysis and machine learning, economic evaluation (cost-effectiveness analysis, cost-benefit analysis, and cost-utility analysis), measurement of efficiency and equity in health services, and health systems financing research.

We cover a broad range of areas in health economics, including:

  • Economic evaluation of new and existing health interventions to estimate the value for money.
  • Development and application of econometric analysis and machine learning to guide health policy decisions.
  • Modelling the impact of population-based interventions on disease and healthcare ustilisation. 
  • Application of big data analytics in health economics.
  • Evaluation of equity and efficiency of inventions and health financing mechanisms.
  • Evaluation of performance of National Health Insurance schemes.

We undertake this research through research grants, student research projects, and short-term consultancies. 

Study health economics

The School of Population Health (SPH) UNSW offers a range of ways to study health economic content. This includes a Master of Public Health specialisation in health economic evaluation and a number different individual Masters courses on:

  • Economic Evaluation in Healthcare
  • Healthcare Economics and Financial Management
  • Advanced Health Economics and Financial Management
  • Health Economics & Finance for Developing Countries

Our people

Our PhD candidates

Levina Chandra Khoe

Thesis title: Economic consequences of underreporting of occupational-related illnesses under the National Insurance Scheme in Indonesia

Umesh Prasad Bhusal

Thesis title: Equity impact of healthcare financing reforms

Monica Torres

Thesis title: Modelling and cost-effectiveness of COVID-19 vaccination strategies in Australia

Our work

A/Professor Anthony Newall conducts innovative research into the cost-effectiveness and equity impact of vaccination and other preventative strategies in Australia and elsewhere. His research covers a broad range of infectious diseases and includes the economic evaluation of prevention strategies for COVID-19 funded under a $1.9 million The Medical Research Future Fund (MRFF) grant using large, linked datasets.

A/Professor Sharma leads the health economics components of multiple major MRFF and NHMRC grants, including a $1 million evaluation of MyMedicare in residential aged care, a $5.2 million national primary care research consortium,  and a $1.24 million partnership grant to improve preventive healthcare for people with intellectual disability. His work integrates advanced econometric methods with policy‑relevant evaluation across complex health and social systems.

A/Professor Augustine Asante’s research program focuses on evaluating the equity and efficiency impacts of health financing mechanisms using economic methods to inform national and global policy on access to quality health services and financial protection. His previous work includes a major evaluation of equity in health system financing in Indonesia, funded by the UK Health Systems Research Initiative (MRC/DFID/Wellcome Trust/ESRC; approximately $1.4 million).

Colllaborate with us

Please contact us if you are interested in collaboration on health economics and financing topics both within Australia and overseas. Prospective PhD candidates and post-doctoral fellows are also welcome to contact us to discuss potential projects. 

Contact us via the emails below to express your interest: